BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Culnane M, Fowler M, Lee SS, McSherry G, Brady M, O'Donnell K, Mofenson L, Gortmaker SL, Shapiro DE, Scott G. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA. 1999;281:151-157. [PMID: 9917118 DOI: 10.1001/jama.281.2.151] [Cited by in Crossref: 223] [Cited by in F6Publishing: 173] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Miller TL, Agostoni C, Duggan C, Guarino A, Manary M, Velasco CA; HIV Working Group. Gastrointestinal and nutritional complications of human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr 2008;47:247-53. [PMID: 18664883 DOI: 10.1097/MPG.0b013e318181b254] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
2 Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, Schluchter MD, Colan SD; Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P(2)C(2) HIV) Study Group. Cardiovascular status of infants and children of women infected with HIV-1 (P(2)C(2) HIV): a cohort study. Lancet 2002;360:368-73. [PMID: 12241776 DOI: 10.1016/S0140-6736(02)09607-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
3 Watts DH. Maternal Therapy for HIV in Pregnancy: . Clinical Obstetrics and Gynecology 2001;44:182-97. [DOI: 10.1097/00003081-200106000-00008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
4 Hansen WF, Yankowitz J. Pharmacologic therapy for medical disorders during pregnancy. Clin Obstet Gynecol 2002;45:136-52. [PMID: 11862065 DOI: 10.1097/00003081-200203000-00014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
5 Lyall E, Blott M, De Ruiter A, Hawkins D, Mercy D, Mitchla Z, Newell M, O'shea S, Smith J, Sunderland J, Webb R, Taylor G. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission: British HIV Association. HIV Medicine 2001;2:314-34. [DOI: 10.1046/j.1464-2662.2001.00082.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 2.4] [Reference Citation Analysis]
6 Nichols SA, Bhatta MP, Lewis J, Vermund SH. Prenatal HIV counseling, testing, and antiretroviral prophylaxis by obstetric and family medicine providers in Alabama. Am J Med Sci 2002;324:305-9. [PMID: 12495296 DOI: 10.1097/00000441-200212000-00003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
7 Bramley D, Graves N, Walker D. The cost effectiveness of universal antenatal screening for HIV in New Zealand: . AIDS 2003;17:741-8. [DOI: 10.1097/00002030-200303280-00013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
8 United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group Members. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000). HIV Clin Trials 2001;2:56-91. [PMID: 11590515 DOI: 10.1310/3ENW-TR0F-UQ0B-GWKD] [Cited by in Crossref: 5] [Cited by in F6Publishing: 87] [Article Influence: 0.2] [Reference Citation Analysis]
9 . Testing for human immunodeficiency virus type 1 (HIV-1) infection in pregnancy. Paediatr Child Health 2001;6:685-97. [PMID: 20084142 DOI: 10.1093/pch/6.9.685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002;359:1178-86. [PMID: 11955535 DOI: 10.1016/S0140-6736(02)08214-4] [Cited by in Crossref: 292] [Cited by in F6Publishing: 85] [Article Influence: 14.6] [Reference Citation Analysis]
11 Newell M. Reducing childhood mortality in poor countries. Transactions of the Royal Society of Tropical Medicine and Hygiene 2003;97:22-4. [DOI: 10.1016/s0035-9203(03)90009-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
12 Rajan R, Seth A, Mukherjee SB, Chandra J. Development assessment of HIV exposed children aged 6-18 months: a cohort study from North India. AIDS Care 2017;29:1404-9. [PMID: 28278563 DOI: 10.1080/09540121.2017.1300629] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
13 Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, Mcintosh K, Lallemant M. Growth of Human Immunodeficiency Virus-Uninfected Children Exposed to Perinatal Zidovudine for the Prevention of Mother-to-Child Human Immunodeficiency Virus Transmission: . The Pediatric Infectious Disease Journal 2006;25:325-32. [DOI: 10.1097/01.inf.0000207398.10466.0d] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
14 Autret-Leca E, Jonville-Béra AP, Cissoko H. [Methods for studying drug risk during pregnancy]. Arch Pediatr 2000;7 Suppl 2:404s-6s. [PMID: 10904789 DOI: 10.1016/s0929-693x(00)80117-7] [Reference Citation Analysis]
15 Lindegren ML, Rhodes P, Gordon L, Fleming P; STATE AND LOCAL HEALTH DEPARTMENT HIV/AIDS SURVEILLANCE PROGRAMS, AND THE PERINATAL SAFETY REVIEW WORKING GROUP. Drug Safety during Pregnancy and in Infants: Lack of Mortality Related to Mitochondrial Dysfunction among Perinatally HIV-Exposed Children in Pediatric HIV Surveillance. Annals of the New York Academy of Sciences 2000;918:222-35. [DOI: 10.1111/j.1749-6632.2000.tb05492.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
16 . HIV-infected pregnant women and vertical transmission in Europe since 1986: . AIDS 2001;15:761-70. [DOI: 10.1097/00002030-200104130-00012] [Cited by in Crossref: 117] [Cited by in F6Publishing: 88] [Article Influence: 5.6] [Reference Citation Analysis]
17 Nozyce ML, Huo Y, Williams PL, Kapetanovic S, Hazra R, Nichols S, Hunter S, Smith R, Seage GR 3rd, Sirois PA; Pediatric HIVAIDS Cohort Study. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age. Pediatr Infect Dis J 2014;33:1128-33. [PMID: 25361407 DOI: 10.1097/INF.0000000000000410] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
18 Mofenson LM. Advances in the prevention of vertical transmission of human immunodeficiency virus. Semin Pediatr Infect Dis 2003;14:295-308. [PMID: 14724794 DOI: 10.1053/j.spid.2003.09.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
19 Hazra R, Stoszek SK, Freimanis Hance L, Pinto J, Marques H, Peixoto M, Alarcon J, Mussi-Pinhata M, Serchuck L; NISDI Pediatric Study Group 2008. Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries. Int J Epidemiol 2009;38:1207-14. [PMID: 19036797 DOI: 10.1093/ije/dyn239] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
20 Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001. HIV Clin Trials 2001;2:227-306. [PMID: 11590532 DOI: 10.1310/RWG0-49RM-GQH4-5BB3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
21 Perinatal HIV Guidelines Working Group. US Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States, February 25, 2000, by the Perinatal. HIV Clinical Trials 2015;1:39-64. [DOI: 10.1310/3unn-lh5n-mcul-65gq] [Cited by in Crossref: 6] [Article Influence: 0.9] [Reference Citation Analysis]
22 Koren G, Klinger G, Ohlsson A. Fetal Pharmacotherapy: . Drugs 2002;62:757-73. [DOI: 10.2165/00003495-200262050-00004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
23 Zaric GS, Bayoumi AM, Brandeau ML, Owens DK. The Cost Effectiveness of Voluntary Prenatal and Routine Newborn HIV Screening in the United States: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2000;25:403-16. [DOI: 10.1097/00126334-200012150-00004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
24 Shetty AK. Perinatally Acquired HIV-1 Infection: Prevention and Evaluation of HIV-Exposed Infants. Seminars in Pediatric Infectious Diseases 2005;16:282-95. [DOI: 10.1053/j.spid.2005.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
25 Minkoff H. Prevention of Mother-to-Child Transmission of HIV: . Clinical Obstetrics and Gynecology 2001;44:210-25. [DOI: 10.1097/00003081-200106000-00010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
26 Durand-Gasselin L, Pruvost A, Dehée A, Vaudre G, Tabone MD, Grassi J, Leverger G, Garbarg-Chenon A, Bénech H, Dollfus C. High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers. Antimicrob Agents Chemother 2008;52:2555-63. [PMID: 18426897 DOI: 10.1128/AAC.01130-07] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
27 Matthews LT, Smit JA, Cu-Uvin S, Cohan D. Antiretrovirals and safer conception for HIV-serodiscordant couples. Curr Opin HIV AIDS 2012;7:569-78. [PMID: 23032734 DOI: 10.1097/COH.0b013e328358bac9] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
28 Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; PACTG 219C Team. Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. Arch Pediatr Adolesc Med 2009;163:164-71. [PMID: 19188649 DOI: 10.1001/archpedi.163.2.164] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
29 Olivero OA, Parikka R, Poirier MC, Vähäkangas K. 3'-azido-3'-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT. Mutat Res 1999;428:41-7. [PMID: 10517977 DOI: 10.1016/s1383-5742(99)00030-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
30 Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, Ciraru-vigneron N, Lacroix C, Rouzioux C, Mandelbrot L, Desguerre I, Rötig A, Mayaux M, Delfraissy J. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. The Lancet 1999;354:1084-9. [DOI: 10.1016/s0140-6736(99)07219-0] [Cited by in Crossref: 472] [Cited by in F6Publishing: 111] [Article Influence: 20.5] [Reference Citation Analysis]
31 Calamandrei G, Rufini O, Valanzano A, Puopolo M. Long-term effects of developmental exposure to zidovudine on exploratory behavior and novelty discrimination in CD-1 mice. Neurotoxicology and Teratology 2002;24:529-40. [DOI: 10.1016/s0892-0362(02)00234-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
32 Leyes M, Villalonga C, Riera M, Salas A, Ribas Á, Ciria L, Ruiz de Gopegui R, Sánchez E, de la Peña A. Prevención de la transmisión vertical del VIH-1 en mallorca. impacto de la terapia antirretroviral desde 1995 a 2000. Medicina Clínica 2002;118:365-70. [DOI: 10.1016/s0025-7753(02)72389-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Nso Roca AP, García-Bermejo CG, Larru B, R M, Muñoz Fernández MA, de José MI. Pathology in children of HIV women. Indian J Pediatr 2009;76:1125-30. [PMID: 20092024 DOI: 10.1007/s12098-009-0225-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
34 Iribarren JA, Ramos JT, Guerra L, Coll O, Isabel de José M, Domingo P, Fortuny C, Miralles P, Parras F, Peña JM, Rodrigo C, Vidal R. Prevención de la transmisión vertical y tratamiento de la infección por el virus de la inmunodeficiencia humana en la mujer embarazada. Enfermedades Infecciosas y Microbiología Clínica 2001;19:314-35. [DOI: 10.1016/s0213-005x(01)72652-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
35 Zaric GS, Bayoumi AM, Brandeau ML, Owens DK. The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States. J Acquir Immune Defic Syndr 2000;25:403-16. [PMID: 11141240 DOI: 10.1097/00042560-200012150-00004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
36 Mayaux MJ, Teglas JP, Blanche S; French Pediatric HIV Infection Study Group. Characteristics of HIV-infected women who do not receive preventive antiretroviral therapy in the French Perinatal Cohort. J Acquir Immune Defic Syndr 2003;34:338-43. [PMID: 14600581 DOI: 10.1097/00126334-200311010-00013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
37 Mataró D, García D, Coll O, Vassena R, Rodríguez A. Lower endometrial receptivity in HIV-infected women receiving oocyte donation: a comorbidity of HIV infection? Hum Reprod Open 2017;2017:hox019. [PMID: 30895233 DOI: 10.1093/hropen/hox019] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy: . The Pediatric Infectious Disease Journal 2003;22:782-8. [DOI: 10.1097/01.inf.0000086400.93257.74] [Cited by in Crossref: 78] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
39 Watts DH. Treating HIV During Pregnancy: An Update on Safety Issues. Drug Safety 2006;29:467-90. [DOI: 10.2165/00002018-200629060-00002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
40 Llorente AM, Lopresti C, Satz P. Neurobehavioral and Neurodevelopmental Sequelae Associated with Pediatric HIV Infection. In: Reynolds CR, Fletcher-janzen E, editors. Handbook of Clinical Child Neuropsychology. Boston: Springer US; 2009. pp. 635-69. [DOI: 10.1007/978-0-387-78867-8_26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 El Beitune P, Duarte G. Antiretroviral agents during pregnancy: consequences on hematologic parameters in HIV-exposed, uninfected newborn infant. Eur J Obstet Gynecol Reprod Biol 2006;128:59-63. [PMID: 16876310 DOI: 10.1016/j.ejogrb.2006.01.013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
42 Bulterys M, Nesheim S, Abrams EJ, Palumbo P, Farley J, Lampe M, Fowler MG; Perinatal Safety Review Working Group. Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study. Ann N Y Acad Sci 2000;918:212-21. [PMID: 11131707 DOI: 10.1111/j.1749-6632.2000.tb05491.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
43 Andiman WA. Transmission of HIV-1 from mother to infant. Curr Opin Pediatr 2002;14:78-85. [PMID: 11880739 DOI: 10.1097/00008480-200202000-00014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
44 Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9(7): 1501-1503 [PMID: 12854150 DOI: 10.3748/wjg.v9.i7.1501] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.5] [Reference Citation Analysis]
45 Bulterys M. Preventing Vertical HIV Transmission in the Year 2000: Progress and Prospects—A Review. Placenta 2001;22:S5-S12. [DOI: 10.1053/plac.2001.0671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
46 Burns DN, Mofenson LM. Paediatric HIV-1 infection. The Lancet 1999;354:SII1-6. [DOI: 10.1016/s0140-6736(99)90249-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
47 Abers MS, Shandera WX, Kass JS. Neurological and psychiatric adverse effects of antiretroviral drugs. CNS Drugs 2014;28:131-45. [PMID: 24362768 DOI: 10.1007/s40263-013-0132-4] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 11.9] [Reference Citation Analysis]
48 Smith R, Wilkins M. Perinatally acquired HIV infection: long-term neuropsychological consequences and challenges ahead. Child Neuropsychol 2015;21:234-68. [PMID: 24697320 DOI: 10.1080/09297049.2014.898744] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
49 Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Landay AL, Baker R, Stek AM, Khoury MM, Proia LA, Kessler HA, Sha BE, Tarone RE, Poirier MC. Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS 1999;13:919-25. [PMID: 10371172 DOI: 10.1097/00002030-199905280-00007] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 4.3] [Reference Citation Analysis]
50 Marsit CJ, Brummel SS, Kacanek D, Seage GR 3rd, Spector SA, Armstrong DA, Lester BM, Rich K; Pediatric HIV/AIDS Cohort Studies Network. Infant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in utero. Epigenetics 2015;10:708-16. [PMID: 26067216 DOI: 10.1080/15592294.2015.1060389] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
51 Fowler MG. Follow-up of children exposed to perinatal antiretrovirals. Teratology 2000;61:395-6. [DOI: 10.1002/(sici)1096-9926(200005)61:5<395::aid-tera15>3.0.co;2-h] [Cited by in Crossref: 9] [Article Influence: 0.4] [Reference Citation Analysis]
52 Bulterys M, Fowler MG. PREVENTION OF HIV INFECTION IN CHILDREN. Pediatric Clinics of North America 2000;47:241-60. [DOI: 10.1016/s0031-3955(05)70203-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
53 Walker DM, Malarkey DE, Seilkop SK, Ruecker FA, Funk KA, Wolfe MJ, Treanor CP, Foley JF, Hahn FF, Hardisty JF, Walker VE. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats. Environ Mol Mutagen 2007;48:283-98. [PMID: 17358026 DOI: 10.1002/em.20297] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
54 Hawkins D, Blott M, Clayden P, de Ruiter A, Foster G, Gilling-Smith C, Gosrani B, Lyall H, Mercey D, Newell ML, O'Shea S, Smith R, Sunderland J, Wood C, Taylor G; BHIVA Guidelines Writing Committee. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med 2005;6 Suppl 2:107-48. [PMID: 16033339 DOI: 10.1111/j.1468-1293.2005.00302.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
55 Singh E, Naidu G, Davies MA, Bohlius J. HIV-associated malignancies in children. Curr Opin HIV AIDS 2017;12:77-83. [PMID: 27685986 DOI: 10.1097/COH.0000000000000331] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
56 Venerosi A, Valanzano A, Puopolo M, Calamandrei G. Neurobehavioral effects of prenatal exposure to AZT: a preliminary investigation with the D1 receptor agonist SKF 38393 in mice. Neurotoxicol Teratol 2005;27:169-73. [PMID: 15681130 DOI: 10.1016/j.ntt.2004.09.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
57 Taylor GP, Low-beer N. Antiretroviral Therapy in Pregnancy: A Focus on Safety. Drug Safety 2001;24:683-702. [DOI: 10.2165/00002018-200124090-00004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
58 Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ; Pediatrics AIDS Clinical Trials Group 288 Protocol Team. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr 2003;32:170-81. [PMID: 12571527 DOI: 10.1097/00126334-200302010-00009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
59 Stringer JS, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH. Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health 2002;92:365-6. [PMID: 11867311 DOI: 10.2105/ajph.92.3.365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
60 Thorne C, Newell M. Epidemiology of HIV infection in the newborn. Early Human Development 2000;58:1-16. [DOI: 10.1016/s0378-3782(00)00049-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
61 Read JS, Huo Y, Patel K, Mitchell M, Scott GB. Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025. J Pediatric Infect Dis Soc 2012;1:92-102. [PMID: 23687574 DOI: 10.1093/jpids/pis036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
62 Thorne C, Newell M. Managing Mother-to-Child Transmission of HIV Infection in Developed-Country Settings. Womens Health (Lond Engl) 2005;1:385-99. [DOI: 10.2217/17455057.1.3.385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Brocklehurst P; Cochrane HIV/AIDS Group. Interventions for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd000102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
64 Mirochnick M, Best BM, Clarke DF. Antiretroviral Pharmacology: Special Issues Regarding Pregnant Women and Neonates. Clinics in Perinatology 2010;37:907-27. [DOI: 10.1016/j.clp.2010.08.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
65 Bongertz V. Vertical human immunodeficiency virus type 1--HIV-1--transmission--a review. Mem Inst Oswaldo Cruz 2001;96:1-14. [PMID: 11285470 DOI: 10.1590/s0074-02762001000100001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
66 Ma L, Alla NR, Li X, Mynbaev OA, Shi Z. Mother-to-child transmission of HBV: review of current clinical management and prevention strategies: Mother-to-child transmission of HBV. Rev Med Virol 2014;24:396-406. [DOI: 10.1002/rmv.1801] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
67 Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS 2007;21:607-15. [PMID: 17314523 DOI: 10.1097/QAD.0b013e32802ef2f6] [Cited by in Crossref: 170] [Cited by in F6Publishing: 65] [Article Influence: 11.3] [Reference Citation Analysis]
68 Chappuy H, Tréluyer JM, Jullien V, Dimet J, Rey E, Fouché M, Firtion G, Pons G, Mandelbrot L. Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother 2004;48:4332-6. [PMID: 15504861 DOI: 10.1128/AAC.48.11.4332-4336.2004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
69 Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A, Vanprapar N, Sirimai K, Chearskul S, Sutthent R, Opartkiattikul N. Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand. Clin Infect Dis 2002;35:1405-13. [PMID: 12439805 DOI: 10.1086/344274] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
70 Jao J, Abrams EJ. Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants. Pediatr Infect Dis J 2014;33:734-40. [PMID: 24378947 DOI: 10.1097/INF.0000000000000224] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
71 Mitchell W. Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Rev 2001;7:211-6. [DOI: 10.1002/mrdd.1029] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
72 Divi RL, Einem TL, Fletcher SL, Shockley ME, Kuo MM, St Claire MC, Cook A, Nagashima K, Harbaugh SW, Harbaugh JW, Poirier MC. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs). Toxicol Sci 2010;118:191-201. [PMID: 20702595 DOI: 10.1093/toxsci/kfq235] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
73 Bishop JB, Witt KL, Tice RR, Wolfe GW. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage. Environ Mol Mutagen 2004;43:3-9. [PMID: 14743340 DOI: 10.1002/em.10210] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
74 Aldrovandi GM, Chu C, Shearer WT, Li D, Walter J, Thompson B, McIntosh K, Foca M, Meyer WA 3rd, Ha BF, Rich KC, Moye J Jr. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women. Pediatrics 2009;124:e1189-97. [PMID: 19933732 DOI: 10.1542/peds.2008-2771] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
75 Benhammou V, Tardieu M, Warszawski J, Rustin P, Blanche S; on behalf of the French Perinatal Cohort. Clinical mitochondrial dysfunction in uninfected children born to HIV-infected mothers following perinatal exposure to nucleoside analogues. Environ Mol Mutagen 2007;48:173-8. [DOI: 10.1002/em.20279] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
76 Englert Y, Van Vooren J, Liesnard C, Laruelle C, Delbaere A. Assistance médicale à la procréation et désir d’enfant de couples infectés par le VIH : le temps d’un changement d’attitude est-il venu ? Gynécologie Obstétrique & Fertilité 2001;29:339-48. [DOI: 10.1016/s1297-9589(01)00143-6] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
77 Poirier MC, Divi RL, Al-Harthi L, Olivero OA, Nguyen V, Walker B, Landay AL, Walker VE, Charurat M, Blattner WA; Women and Infants Transmission Study (WITS) Group. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 2003;33:175-83. [PMID: 12794551 DOI: 10.1097/00126334-200306010-00010] [Cited by in Crossref: 115] [Cited by in F6Publishing: 105] [Article Influence: 6.1] [Reference Citation Analysis]
78 Ciaranello AL, Seage GR 3rd, Freedberg KA, Weinstein MC, Lockman S, Walensky RP. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS 2008;22:2359-69. [PMID: 18981776 DOI: 10.1097/QAD.0b013e3283189bd7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
79 Mirochnick M. Antiretroviral Pharmacology in Pregnant Women and Their Newborns. Annals of the New York Academy of Sciences 2000;918:287-97. [DOI: 10.1111/j.1749-6632.2000.tb05498.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
80 Piske M, Budd MA, Qiu AQ, Maan EJ, Sauvé LJ, Forbes JC, Alimenti A, Janssen P, Côté HCF; CIHR Team Grant on Cellular Aging and HIV Comorbidities in Women and Children (CARMA). Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children. AIDS 2018;32:2583-92. [PMID: 30134292 DOI: 10.1097/QAD.0000000000001985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
81 Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet 2000;355:2237-44. [PMID: 10881908 DOI: 10.1016/S0140-6736(00)02415-6] [Cited by in Crossref: 136] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
82 D'Cruz OJ, Uckun FM. Lack of adverse effects on fertility of female CD-1 mice exposed to repetitive intravaginal gel-microemulsion formulation of a dual-function anti-HIV agent: aryl phosphate derivative of bromo-methoxy-zidovudine (compound WHI-07). J Appl Toxicol 2001;21:317-22. [PMID: 11481666 DOI: 10.1002/jat.762] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
83 Mofenson LM, Munderi P. Safety of Antiretroviral Prophylaxis of Perinatal Transmission for HIV-Infected Pregnant Women and Their Infants: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2002;30:200-15. [DOI: 10.1097/00042560-200206010-00010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 2.8] [Reference Citation Analysis]
84 Venhoff N, Walker UA. Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf 2006;5:373-81. [PMID: 16610967 DOI: 10.1517/14740338.5.3.373] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
85 Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, Kumar S, Pignatelli RH, Bezold LI, LaRussa P, Starc TJ, Glickstein JS, O'Brien S, Cooper ER, Wilkinson JD, Miller TL, Colan SD. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol 2011;57:76-85. [PMID: 21185505 DOI: 10.1016/j.jacc.2010.08.620] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
86 Bavoux F, Loubeyre-unique C, Blanche S. Antirétroviraux et grossesse: à propos d'une alerte sur pathologie mitochondriale et analogues nucléosidiques. Archives de Pédiatrie 2000;7:407s-8s. [DOI: 10.1016/s0929-693x(00)80118-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
87 Dagan T, Sable C, Bray J, Gerschenson M. Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence? Mitochondrion 2002;1:397-412. [DOI: 10.1016/s1567-7249(02)00003-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
88 Taha TE, Kumwenda N, Kafulafula G, Kumwenda J, Chitale R, Nkhoma C, Katundu P, Mukiibi J, Chen S, Hoover D, Broadhead R. Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth. Annals of Tropical Paediatrics 2013;24:301-9. [DOI: 10.1179/027249304225019127] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
89 Fan W, Christian KM, Song H, Ming GL. Applications of Brain Organoids for Infectious Diseases. J Mol Biol 2021;:167243. [PMID: 34536442 DOI: 10.1016/j.jmb.2021.167243] [Reference Citation Analysis]
90 Koh M, Shinohara J, Hongo Y, Okazaki T, Takitani K, Tamai H. Case treated with triple therapy of lamivudine, interferon-β and prednisolone for acute exacerbation of chronic hepatitis B during pregnancy. Hepatol Res. 2013;43:425-429. [PMID: 23560863 DOI: 10.1111/j.1872-034x.2012.01077.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
91 Lewis W. Absence of cardiac toxicity of zidovudine in infants. N Engl J Med 2001;344:458. [PMID: 11221608 DOI: 10.1056/NEJM200102083440613] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
92 . Care of the infant born to an HIV-positive mother. Paediatr Child Health 2000;5:161-70. [PMID: 20177515 DOI: 10.1093/pch/5.3.161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
93 Moodley D, Pillay K, Naidoo K, Moodley J, Johnson MA, Moore KHP, Mudd PN, Pakes GE. Pharmacokinetics of Zidovudine and Lamivudine in Neonates following Coadministration of Oral Doses Every 12 Hours. The Journal of Clinical Pharmacology 2001;41:732-41. [DOI: 10.1177/00912700122010636] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
94 Yadav SK, Gupta RK, Hashem S, Nisar S, Azeem T, Bhat AA, Syed N, Garg RK, Venkatesh V, Kamal M, Fakhro K, Frenneaux MP, Haris M. Brain microstructural changes support cognitive deficits in HIV uninfected children born to HIV infected mothers. Brain Behav Immun Health 2020;2:100039. [PMID: 34589830 DOI: 10.1016/j.bbih.2020.100039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Divi RL, Walker VE, Wade NA, Nagashima K, Seilkop SK, Adams ME, Nesel CJ, O'neill JP, Abrams EJ, Poirier MC. Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir: . AIDS 2004;18:1013-21. [DOI: 10.1097/00002030-200404300-00009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 2.9] [Reference Citation Analysis]
96 Venerosi A, Calamandrei G, Alleva E. Animal models of anti-HIV drugs exposure during pregnancy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002;26:747-61. [DOI: 10.1016/s0278-5846(01)00325-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
97 Kriebs JM. The Global Reach of HIV: Preventing Mother-to-Child Transmission. The Journal of Perinatal & Neonatal Nursing 2002;16:1-10. [DOI: 10.1097/00005237-200212000-00003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
98 Barret B, Tardieu M, Rustin P, Lacroix C, Chabrol B, Desguerre I, Dollfus C, Mayaux M, Blanche S. Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort. AIDS 2003;17:1769-85. [DOI: 10.1097/00002030-200308150-00006] [Cited by in Crossref: 195] [Cited by in F6Publishing: 151] [Article Influence: 10.3] [Reference Citation Analysis]
99 Calamandrei G, Venerosi A, Branchi I, Valanzano A, Alleva E. Prenatal exposure to anti-HIV drugs. long-term neurobehavioral effects of lamivudine (3TC) in CD-1 mice. Neurotoxicol Teratol. 2000;22:369-379. [PMID: 10840180 DOI: 10.1016/s0892-0362(00)00063-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
100 Calamandrei G, Venerosi A, Valanzano A, Alleva E. Effects of prenatal AZT+3TC treatment on open field behavior and responsiveness to scopolamine in adult mice. Pharmacology Biochemistry and Behavior 2000;67:511-7. [DOI: 10.1016/s0091-3057(00)00386-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
101 El-Beitune P, Duarte G, de Morais EN, Campbell O, Spara-Gadelha P, Mauad-Filho F, Quintana SM, Rodrigues LC. Antiretroviral agents and acid-base balance at delivery of the neonate. Braz J Med Biol Res 2007;40:957-61. [PMID: 17653449 DOI: 10.1590/s0100-879x2006005000126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Mandelbrot L, Peytavin G, Firtion G, Farinotti R. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus–infected pregnant women. American Journal of Obstetrics and Gynecology 2001;184:153-8. [DOI: 10.1067/mob.2001.108344] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
103 Moschovi M, Theodoridou M, Papaevangelou V, Tzortzatou-stathopoulou F. Acute lymphoblastic leukaemia in an infant exposed to zidovudine in utero and early infancy: . AIDS 2000;14:2410-1. [DOI: 10.1097/00002030-200010200-00028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
104 Onwuamah CK, Ezechi OC, Herbertson EC, Audu RA, Ujah IA, Odeigah PG. Foetal loss and enhanced fertility observed in mice treated with Zidovudine or Nevirapine. PLoS One 2014;9:e107899. [PMID: 25233270 DOI: 10.1371/journal.pone.0107899] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
105 Fernández Ibieta M, Bellón Cano JM, Ramos Amador JT, González-Tomé MI, Guillén Martín S, Navarro Gómez M, De José MI, Beceiro J, Iglesias E, Prieto L, Santos MJ, Martínez Guardia N, Roa MA, Regidor J. [Growth of uninfected infants exposed to antiretrovirals born to HIV-infected woman]. An Pediatr (Barc) 2009;71:299-309. [PMID: 19660998 DOI: 10.1016/j.anpedi.2009.06.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
106 Sirois PA, Huo Y, Williams PL, Malee K, Garvie PA, Kammerer B, Rich K, Van Dyke RB, Nozyce ML; Pediatric HIVAIDS Cohort Study. Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants. Pediatr Infect Dis J 2013;32:648-55. [PMID: 23340561 DOI: 10.1097/INF.0b013e318284129a] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
107 Venerosi A, Valanzano A, Alleva E, Calamandrei G. Prenatal exposure to anti-HIV drugs: Neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice. Teratology 2001;63:26-37. [DOI: 10.1002/1096-9926(200101)63:1<26::aid-tera1005>3.0.co;2-g] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
108 Ezeamama AE, Zalwango SK, Sikorskii A, Tuke R, Musoke PM, Giordani B, Boivin MJ. In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study. HIV Med 2021;22:592-604. [PMID: 33860626 DOI: 10.1111/hiv.13094] [Reference Citation Analysis]
109 Moran GJ. PHARMACOLOGIC MANAGEMENT OF HIV/STD EXPOSURE. Emergency Medicine Clinics of North America 2000;18:829-42. [DOI: 10.1016/s0733-8627(05)70161-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
110 Shannon M. Antiretroviral Therapy in HIV-Infected Pregnant Women and Their Infants: Current Interventions and Challenges. The Journal of Perinatal & Neonatal Nursing 2002;16:1-25. [DOI: 10.1097/00005237-200209000-00003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
111 Le Chenadec J, Mayaux M, Guihenneuc-jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants: . AIDS 2003;17:2053-61. [DOI: 10.1097/00002030-200309260-00006] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 6.2] [Reference Citation Analysis]
112 Crain MJ, Williams PL, Griner R, Tassiopoulos K, Read JS, Mofenson LM, Rich KC; Pediatric HIVAIDS Cohort Study. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications. Pediatr Infect Dis J 2011;30:1069-74. [PMID: 22051859 DOI: 10.1097/INF.0b013e318234c886] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
113 Siegfried N, van der Merwe L, Brocklehurst P, Sint TT; Cochrane HIV/AIDS Group. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd003510.pub3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 96] [Article Influence: 5.4] [Reference Citation Analysis]
114 Lindegren ML, Steinberg S, Byers RH Jr. Epidemiology of HIV/AIDS in children. Pediatr Clin North Am 2000;47:1-20, v. [PMID: 10697639 DOI: 10.1016/s0031-3955(05)70192-9] [Cited by in Crossref: 58] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
115 Diwan BA, Riggs CW, Logsdon D, Haines DC, Olivero OA, Rice JM, Yuspa SH, Poirier MC, Anderson LM. Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice. Toxicol Appl Pharmacol 1999;161:82-99. [PMID: 10558926 DOI: 10.1006/taap.1999.8782] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 2.3] [Reference Citation Analysis]
116 Shetty AK, Maldonado YA. Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Infant. Infectious Diseases of the Fetus and Newborn. Elsevier; 2011. pp. 622-60. [DOI: 10.1016/b978-1-4160-6400-8.00021-3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
117 Cho J, Holditch-Davis D, Miles MS. Effects of gender on the health and development of medically at-risk infants. J Obstet Gynecol Neonatal Nurs 2010;39:536-49. [PMID: 20920000 DOI: 10.1111/j.1552-6909.2010.01171.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
118 Bae WH, Wester C, Smeaton LM, Shapiro RL, Lockman S, Onyait K, Thior I, Essex M. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants. AIDS 2008;22:1633-40. [PMID: 18670224 DOI: 10.1097/QAD.0b013e328307a029] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
119 Freedman D, Koenig LJ, Wiener J, Abrams EJ, Carter RJ, Tepper V, Palumbo P, Nesheim S, Bulterys M. Challenges to re-enrolling perinatally HIV-infected and HIV-exposed but uninfected children into a prospective cohort study: strategies for locating and recruiting hard-to-reach families. Paediatr Perinat Epidemiol 2006;20:338-47. [PMID: 16879506 DOI: 10.1111/j.1365-3016.2006.00742.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
120 Andany N, Loutfy MR. HIV protease inhibitors in pregnancy : pharmacology and clinical use. Drugs 2013;73:229-47. [PMID: 23404092 DOI: 10.1007/s40265-013-0017-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
121 Geromanos K, Sunkle SN, Mauer MB, Carp D, Ancker J, Zhang W, Easley KA, Schluchter MD, Kozinetz CA, Mellins RB. Successful techniques for retaining a cohort of infants and children born to HIV-infected women: the prospective P2C2 HIV study. J Assoc Nurses AIDS Care 2004;15:48-57. [PMID: 15296658 DOI: 10.1177/1055329003256653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
122 Cibulka NJ. Mother-to-child transmission of HIV in the United States. Many HIV-infected women are now planning to have children. What are the risks to mother and infant? Am J Nurs 2006;106:56-63; quiz 64. [PMID: 16801790 DOI: 10.1097/00000446-200607000-00029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
123 Patchen L, Beal MW. Preventing Perinatal Transmission of HIV: An Evidence-Based Update For Midwives. Journal of Midwifery & Women's Health 2001;46:354-65. [DOI: 10.1016/s1526-9523(01)00197-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
124 Stratigos JD, Johnson RA, Stratigos A. HIV disease in the year 2000. Clin Dermatol 2000;18:375-9. [PMID: 11024304 DOI: 10.1016/s0738-081x(99)00132-7] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
125 Onwuamah CK, Ekama SO, Audu RA, Ezechi OC, Poirier MC, Odeigah PG. Exposure of Allium cepa root cells to zidovudine or nevirapine induces cytogenotoxic changes. PLoS One 2014;9:e90296. [PMID: 24599327 DOI: 10.1371/journal.pone.0090296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
126 Hankin C, Lyall H, Willey B, Peckham C, Masters J, Tookey P. In utero exposure to antiretroviral therapy: feasibility of long-term follow-up. AIDS Care 2009;21:809-16. [DOI: 10.1080/09540120802513717] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
127 Ngoma MS, Hunter JA, Harper JA, Church PT, Mumba S, Chandwe M, Côté HC, Albert AY, Smith M, Selemani C, Sandstrom PA, Bandenduck L, Ndlovu U, Khan S, Roa L, Silverman MS. Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding. AIDS 2014;28:S323-30. [DOI: 10.1097/qad.0000000000000357] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
128 Keiser O, Gayet-ageron A, Rudin C, Brinkhof MW, Gremlich E, Wunder D, Drack G, Hirschel B, de Tejada BM. Antiretroviral treatment during pregnancy. AIDS 2008;22:2323-30. [DOI: 10.1097/qad.0b013e3283189bf1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
129 Brocklehurst P, Volmink J, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd003510] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
130 Carneiro M, Sanchéz A, Maneiro P, Angelosante W, Pérez C, Valleé M. Vertical HIV-1 Transmission: Prophylaxis and Paediatric Follow-Up. Placenta 2001;22:S13-8. [DOI: 10.1053/plac.2001.0670] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
131 . Does Exposure to Antiretroviral Therapy Affect Growth in the First 18 Months of Life in Uninfected Children Born to HIV-Infected Women? JAIDS Journal of Acquired Immune Deficiency Syndromes 2005;40:364-70. [DOI: 10.1097/01.qai.0000162417.62748.cd] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
132 Dabis F, Elenga N, Meda N, Leroy V, Viho I, Manigart O, Dequae-Merchadou L, Msellati P, Sombie I; DITRAME Study Group. 18-Month mortality and perinatal exposure to zidovudine in West Africa. AIDS 2001;15:771-9. [PMID: 11371692 DOI: 10.1097/00002030-200104130-00013] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
133 Poulton J, Lyall H, Taylor G, Williams GT. HIV-1 therapy and fetal mitochondrial dysfunction. The Lancet 1999;354:2081-2. [DOI: 10.1016/s0140-6736(05)76823-9] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
134 Miller RK. Anti-HIV therapy during pregnancy: Risk-benefit ratio. Teratology 2000;62:288-90. [DOI: 10.1002/1096-9926(200011)62:5<288::aid-tera2>3.0.co;2-9] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
135 Herrero D, Gallo PR, Fujimori M, de Mello Monteiro CB, Valenti VE, Tavares CM, Gallo SM, Macedo CC, Oliveira AG, de Abreu LC. Motor development of infants exposed to maternal human immunodeficiency virus (HIV) but not infected. Int Arch Med 2013;6:45. [PMID: 24171763 DOI: 10.1186/1755-7682-6-45] [Reference Citation Analysis]
136 Watts DH, Huang S, Culnane M, Kaiser KA, Scheuerle A, Mofenson L, Stanley K, Newell ML, Mandelbrot L, Delfraissy JF, Cunningham CK. Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication. J Perinat Med 2011;39:163-70. [PMID: 21142844 DOI: 10.1515/jpm.2010.139] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
137 Olivero OA, Fernandez JJ, Antiochos BB, Wagner JL, St. Claire ME, Poirier MC. Transplacental Genotoxicity of Combined Antiretroviral Nucleoside Analogue Therapy in Erythrocebus patas Monkeys: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2002;29:323-9. [DOI: 10.1097/00126334-200204010-00001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
138 Fernández Ibieta M, Ramos Amador JT, González Tomé MI, Guillén Martín S, Bellón Cano JM, Navarro Gómez M, de José MI, Beceiro J, Iglesias E, Rubio B. [Anaemia and neutropenia in a cohort of non-infected children of HIV-positive mothers]. An Pediatr (Barc). 2008;69:533-543. [PMID: 19128766 DOI: 10.1016/s1695-4033(08)75236-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
139 &NA;. Pregnancy and HIV infection: a European consensus on management: Executive summary. AIDS 2002;16:S1-S18. [DOI: 10.1097/00002030-200206022-00001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
140 Leite C, Barbosa A, Lucato LT. Viral Diseases of the Central Nervous System. Topics in Magnetic Resonance Imaging 2005;16:189-212. [DOI: 10.1097/01.rmr.0000189108.55275.12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
141 Blanche S, Tardieu M, Benhammou V, Warszawski J, Rustin P. Mitochondrial dysfunction following perinatal exposure to nucleoside analogues. AIDS 2006;20:1685-90. [PMID: 16931932 DOI: 10.1097/01.aids.0000242814.42344.77] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
142 Volmink J, Siegfried N, van der Merwe L, Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd003510.pub2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.0] [Reference Citation Analysis]
143 Mor ris AA, Carr A. HIV nucleoside analogues: new adverse effects on mitochondria? The Lancet 1999;354:1046-7. [DOI: 10.1016/s0140-6736(99)00301-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 1] [Article Influence: 1.9] [Reference Citation Analysis]
144 Soler-Palacín P, Martín-Nalda A, Martínez-Gómez X, Melendo S, Riudor E, Arranz JA, Espiau M, Figueras C. Hyperlactatemia and in utero exposure to antiretrovirals: is the control group the clue? AIDS Res Hum Retroviruses 2012;28:752-8. [PMID: 22010980 DOI: 10.1089/AID.2011.0198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
145 Wutzler P, Thust R. Genetic risks of antiviral nucleoside analogues--a survey. Antiviral Res 2001;49:55-74. [PMID: 11248359 DOI: 10.1016/s0166-3542(00)00139-x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
146 Fiore S, Newell M. Preventing perinatal transmission of HIV-1 infection. Hospital Medicine 2000;61:315-8. [DOI: 10.12968/hosp.2000.61.5.1329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
147 Hankin C, Lyall H, Peckham C, Tookey P. Monitoring death and cancer in children born to HIV-infected women in England and Wales: use of HIV surveillance and national routine data. AIDS 2007;21:867-9. [PMID: 17415042 DOI: 10.1097/QAD.0b013e3280b01822] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
148 Thorne C, Newell M. Safety of Agents Used to Prevent Mother-to-Child Transmission of HIV: Is There Any Cause for Concern? Drug Safety 2007;30:203-13. [DOI: 10.2165/00002018-200730030-00004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
149 Fausto MA, Carneiro M, Antunes CMF, Colosimo EA, Pinto JA. Longitudinal anthropometric assessment of infants born to HIV-1-infected mothers, Belo Horizonte, Southeastern Brazil. Rev Saúde Pública 2011;45:652-60. [DOI: 10.1590/s0034-89102011005000040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
150 Briand N, Lallemant M, Jourdain G, Techapalokul S, Tunthanathip P, Suphanich S, Chanpoo T, Traisathit P, McIntosh K, Le Coeur S. Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: secondary analysis of a randomized trial. PLoS Clin Trials 2007;2:e11. [PMID: 17476315 DOI: 10.1371/journal.pctr.0020011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
151 Khoury M, Kovacs A. Pediatric HIV infection. Clin Obstet Gynecol 2001;44:243-75. [PMID: 11344991 DOI: 10.1097/00003081-200106000-00012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
152 Garbis H, van Tonningen MR, Reuvers M. Anti-infective agents. Drugs During Pregnancy and Lactation. Elsevier; 2007. pp. 123-77. [DOI: 10.1016/b978-0-444-52072-2.50010-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
153 . Exposure to Antiretroviral Therapy in Utero or Early Life: the Health of Uninfected Children Born to HIV-Infected Women: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2003;32:380-7. [DOI: 10.1097/00126334-200304010-00006] [Cited by in Crossref: 144] [Cited by in F6Publishing: 130] [Article Influence: 7.6] [Reference Citation Analysis]
154 Goldenberg RL, Stringer JSA, Sinkala M, Vermund SH. Perinatal HIV transmission: developing country considerations. The Journal of Maternal-Fetal & Neonatal Medicine 2009;12:149-58. [DOI: 10.1080/jmf.12.3.149.158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
155 Siegel K, Lekas H, Schrimshaw EW, Johnson JK. Factors Associated With HIV-Infected Women's Use or Intention to Use AZT During Pregnancy. AIDS Education and Prevention 2001;13:189-206. [DOI: 10.1521/aeap.13.3.189.19747] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
156 Witt KL, Tice RR, Wolfe GW, Bishop JB. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment. Environ Mol Mutagen 2004;44:321-8. [PMID: 15476197 DOI: 10.1002/em.20048] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
157 Fujinaga M, Schulte M, Holodniy M. Assessment of developmental toxicity of antiretroviral drugs using a rat whole embryo culture system. Teratology 2000;62:108-14. [DOI: 10.1002/1096-9926(200008)62:2<108::aid-tera7>3.0.co;2-2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
158 Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants. Pediatrics 2010;125:e250-60. [PMID: 20083530 DOI: 10.1542/peds.2009-1112] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
159 Neri D, Somarriba GA, Schaefer NN, Chaparro AI, Scott GB, Lopez Mitnik G, Ludwig DA, Miller TL. Growth and body composition of uninfected children exposed to human immunodeficiency virus: comparison with a contemporary cohort and United States National Standards. J Pediatr 2013;163:249-54.e1-2. [PMID: 23360565 DOI: 10.1016/j.jpeds.2012.12.034] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
160 Gaillard P, Fowler M, Dabis F, Coovadia H, van der Horst C, van Rompay K, Ruff A, Taha T, Thomas T, de Vincenzi I, Newell M. Use of Antiretroviral Drugs to Prevent HIV-1 Transmission Through Breast-feeding: From Animal Studies to Randomized Clinical Trials: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2004;35:178-87. [DOI: 10.1097/00126334-200402010-00013] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
161 Rodman JH. Design of antiretroviral clinical trials for HIV-1 infected pregnant women and their newborn infants. Semin Perinatol 2001;25:170-6. [PMID: 11453614 DOI: 10.1053/sper.2001.24904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
162 Shi Z, Yang Y, Ma L, Li X, Schreiber A. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010;116:147-159. [PMID: 20567182 DOI: 10.1097/aog.0b013e3181e45951] [Cited by in Crossref: 120] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
163 Santini-Oliveira M, Grinsztejn B. Adverse drug reactions associated with antiretroviral therapy during pregnancy. Expert Opin Drug Saf 2014;13:1623-52. [PMID: 25390463 DOI: 10.1517/14740338.2014.975204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
164 Moran GJ. Emergency department management of blood and body fluid exposures. Annals of Emergency Medicine 2000;35:47-62. [DOI: 10.1016/s0196-0644(00)70104-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Ivy W 3rd, Nesheim SR, Paul SM, Ibrahim AR, Chan M, Niu X, Lampe MA. Cancer Among Children With Perinatal Exposure to HIV and Antiretroviral Medications--New Jersey, 1995-2010. J Acquir Immune Defic Syndr 2015;70:62-6. [PMID: 26017660 DOI: 10.1097/QAI.0000000000000695] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
166 Côté H, Raboud J, Bitnun A, Alimenti A, Money D, Maan E, Costei A, Gadawski I, Diong C, Read S, Shen S, Harrigan P, Burdge D, King S, Forbes J. Perinatal Exposure to Antiretroviral Therapy Is Associated with Increased Blood Mitochondrial DNA Levels and Decreased Mitochondrial Gene Expression in Infants. J INFECT DIS 2008;198:851-9. [DOI: 10.1086/591253] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
167 Shetty AK, Maldonado Y. Advances in the Prevention of Perinatal HIV-1 Transmission. NeoReviews 2005;6:e12-25. [DOI: 10.1542/neo.6-1-e12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
168 Anderson V, Carneiro M, Bulterys M, Douglas G, Polliotti B, Slikker W. Perinatal Infections: HIV and Co-Infections in the Placenta and Therapeutic Interventions—A Workshop Report. Placenta 2001;22:S34-7. [DOI: 10.1053/plac.2001.0641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
169 Rovira MT, Antorn MT, Payá A, Castellanos E, Mur A, Carreras R. Human immunodeficiency virus infection in pregnant women, transmission and zidovudine therapy. Eur J Obstet Gynecol Reprod Biol 2001;97:46-9. [PMID: 11435008 DOI: 10.1016/s0301-2115(00)00499-1] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
170 Coelho AV, Tricarico PM, Celsi F, Crovella S. Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children. Int J Mol Sci 2017;18:E423. [PMID: 28212307 DOI: 10.3390/ijms18020423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
171 Hankin CD, Newell ML, Tookey P. Long-term follow-up of uninfected children born to HIV-infected women and exposed to antiretroviral therapy: survey of parents' and health professionals' views. AIDS Care 2007;19:482-6. [PMID: 17453587 DOI: 10.1080/09540120701203287] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
172 Smith ML, Puka K, Sehra R, Read SE, Bitnun A. Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3-5 years of age, exposed pre- and perinatally to anti-retroviral medications. AIDS Care 2017;29:1302-8. [PMID: 28482682 DOI: 10.1080/09540121.2017.1325436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
173 Funk MJ, Belinson SE, Pimenta JM, Morsheimer M, Gibbons DC. Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy. Drug Saf 2007;30:845-59. [PMID: 17867723 DOI: 10.2165/00002018-200730100-00004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
174 Abdool Karim S, Abdool Karim Q, Adhikari M, Cassol S, Chersich M, Cooper P, Coovadia A, Coovadia H, Cotton M, Coutsoudis A, Hide W, Hussey G, Maartens G, Madhi S, Martin D, Pettifor JM, Rollins N, Sherman G, Thula S, Urban M, Velaphi S, Williamson C. Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet 2002;359:992-3. [PMID: 11937176 DOI: 10.1016/s0140-6736(02)08063-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
175 Hignett R, Fernando R. Anesthesia for the pregnant HIV patient. Anesthesiol Clin 2008;26:127-43, vii. [PMID: 18319184 DOI: 10.1016/j.anclin.2007.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
176 Andolsek KM, Kelton GM. Risk assessment. Prim Care 2000;27:71-103. [PMID: 10739458 DOI: 10.1016/s0095-4543(05)70149-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]